In the US, largely yes: as of 2026, hemp-derived CBG is generally legal at the federal level under the 2018 Farm Bill if the product holds ≤0.3% delta-9 THC, with states adding rules of their own. Cross a border and the answer changes. The EU classifies CBG as an unauthorized novel food, and Canada regulates it as cannabis. General information, not legal advice; verify locally.
Generally yes, at the federal level. As of 2026, the 2018 Farm Bill covers hemp-derived CBG when the product contains ≤0.3% delta-9 THC by dry weight. Food is where it gets harder: the FDA has not authorized CBG as a dietary supplement or food, and state laws vary on top of that. Not legal advice; verify locally.
Not necessarily. Federal law allows hemp-derived CBG (≤0.3% delta-9 THC) under the 2018 Farm Bill, but each state writes its own rules, and some restrict hemp cannabinoids or particular product types. Where you live and what kind of product it is both matter, so check your state's current law. General information, not legal advice.
It depends on the country. The EU classifies CBG as a novel food, so it needs authorization before it can be sold as a food or supplement. Canada regulates every phytocannabinoid, CBG included, under the Cannabis Act. In the UK, CBG sits outside drug control but inside the FSA novel-food regime. Not legal advice; verify locally.
The same answers on the CBG monograph, in the legality group of its common questions. CBG by condition holds the graded claim for each condition people ask about.
CBG acts on α2-adrenoceptors, which help regulate blood pressure; anyone taking cardiovascular medication should consult a clinician before using CBG products. Nothing on this page is medical advice, and no statement here is a claim that CBG treats, cures, or prevents any condition. Report a safety event. Peregrine Biopharma funds the platform and holds no editorial authority.